Antineoplastic Combined Chemotherapy ProtocolsInflammationInflammation MediatorsCytokinesChemotherapy, AdjuvantMice, Inbred C57BLTumor Necrosis Factor-alphaLipopolysaccharidesInterleukin-8Interleukin-6NF-kappa BMacrophagesCells, CulturedToll-Like Receptor 4Toll-Like Receptor 2Signal TransductionAntineoplastic AgentsMice, KnockoutCombined Modality TherapyCisplatinCell LineInterleukin-1betaMonocytesCyclophosphamideDoxorubicinRNA, MessengerTreatment OutcomeGene Expression RegulationMice, Inbred BALB CMyeloid Differentiation Factor 88ChemokinesSeoul virusDisease Models, AnimalInterleukin-1Immunity, InnateToll-Like ReceptorsUp-RegulationInterleukin-10Time FactorsNeoadjuvant TherapyEpithelial CellsReverse Transcriptase Polymerase Chain ReactionLungMicrogliaMacrophage ActivationDisease-Free SurvivalEnzyme-Linked Immunosorbent AssayNeutrophilsBreast NeoplasmsChemokine CCL2Interferon-gammaEtoposideSurvival AnalysisGene ExpressionNeoplasm StagingApoptosisDose-Response Relationship, DrugLung NeoplasmsSurvival RateMacrophages, PeritonealPrognosisDrug Administration ScheduleNitric Oxide Synthase Type IIAnti-Inflammatory AgentsEndothelial CellsFlow CytometryToll-Like Receptor 9Blotting, Westernp38 Mitogen-Activated Protein KinasesHMGB1 ProteinIntercellular Adhesion Molecule-1MethotrexateToll-Like Receptor 6SepsisDendritic CellsSpleenAntigens, CD14Leukemia Virus, MurineMembrane GlycoproteinsCarboplatinI-kappa B ProteinsPaclitaxelCyclooxygenase 2Interleukin-12VinblastineMice, Inbred C3HInduction ChemotherapyDown-RegulationRecombinant ProteinsMacrophages, AlveolarNitric OxideTranscription Factor RelAReceptors, ImmunologicChemokine CCL5Mice, TransgenicCell Line, TumorTaxoidsPhagocytosisNeoplasm Recurrence, LocalBurkholderia cenocepacia